Two new members of the lg superfamily, the Lutheran (Lu) blood group glycoprotein and the B-cell adhesion molecule (B-CAM) epithelial cancer antigen, have been recently cloned from human placenta and colon cancer HT29 cell line, respectively. Although amino acid sequences deduced from cDNA analysis suggested that B-CAM should represent an abridged form of the Lu glycoprotein lacking the last 40 amino acids of the putative cytoplasmic tail, the relationship between the genes encoding these polypeptides has not been determined. In the present report, we showed by Southern blot analysis that the Lu and B-CAM cDNAs derived from a unique LUgene which exhibited an Hindlll RFLP associated with the Lu'/Lub blood group polymorphism. Accordingly, in situ hybridization of the Lu cDNA probe confirmed the localization of the Lutheran blood group locus t o chromosome 19 q13.2-13.3, as previously shown for a B-HE LUTHERAN (Lu) blood group antigens were originally shown to be carried by low abundance erythrocyte membrane glycoproteins of apparent molecular mass 85 (major species) and 78 kD (minor species) on immunoblots. I.' Further studies indicated that these glycoproteins (gp), or related molecules, although restricted to erythroid cells in peripheral blood,3 are expressed in a broad range of human cells and tissues and may represent developmentally regulated molecules in human l i~e r .~.~ Recently, the primary structure of the 85 kD Lu gp was deduced from the nucleotide sequence of a human placenta cDNA clone.5 Hydropathy plot analysis indicated that the predicted mature protein is a type I membrane polypeptide of 597 amino acids composed of a large extracellular domain of 518 residues with five potential N-glycosylation sites, followed by a single transmembrane domain and a cytoplasmic tail of 59 amino-acids. Immunochemical studies with antibodies against the extracellular'. ' and the cytoplasmic and/or transmembrane' domains of erythrocyte Lu gp suggested that the 85 kD and 78 kD gp species differ only by the length of the cytoplasmic tail, which contains a consensus binding site for proteins carrying a Src homology 3 d~m a i n .~ Most interestingly, comparison of the predicted amino acid sequence of Lu gp with protein data bases revealed significant homology with numerous members of the Ig superfamily (IgSF). The extracellular part of Lu gp consists of five IgSF-like domains, two variable-(V)-region and three constant-region-2 (C2) set dom a i n~.~ In independent and previous studies, the human basal cell adhesion molecule (B-CAM), a cell surface antigen of epithelial cancer, has been cloned and shown to be also a new IgSF member with the V-V-C2-C2-C2 arrangement of immunoglobulin domains.6 cDNA sequence comparison provided the first indication of a relationship between B-CAM and Lu and indicated that the predicted amino acid sequence of B-CAM differed from that of the 85 kD Lu gp only by the lack of the last 40 amino acids of the cytoplasmic tail.5
HE LUTHERAN (Lu) blood group antigens were originally shown to be carried by low abundance erythrocyte membrane glycoproteins of apparent molecular mass 85 (major species) and 78 kD (minor species) on immunoblots. I. ' Further studies indicated that these glycoproteins (gp), or related molecules, although restricted to erythroid cells in peripheral blood,3 are expressed in a broad range of human cells and tissues and may represent developmentally regulated molecules in human l i~e r .~.~ Recently, the primary structure of the 85 kD Lu gp was deduced from the nucleotide sequence of a human placenta cDNA clone.5 Hydropathy plot analysis indicated that the predicted mature protein is a type I membrane polypeptide of 597 amino acids composed of a large extracellular domain of 518 residues with five potential N-glycosylation sites, followed by a single transmembrane domain and a cytoplasmic tail of 59 amino-acids. Immunochemical studies with antibodies against the extracellular'. ' and the cytoplasmic and/or transmembrane' domains of erythrocyte Lu gp suggested that the 85 kD and 78 kD gp species differ only by the length of the cytoplasmic tail, which contains a consensus binding site for proteins carrying a Src homology 3 d~m a i n .~ Most interestingly, comparison of the predicted amino acid sequence of Lu gp with protein data bases revealed significant homology with numerous members of the Ig superfamily (IgSF). The extracellular part of Lu gp consists of five IgSF-like domains, two variable-(V)-region and three constant-region-2 (C2) set dom a i n~.~ In independent and previous studies, the human basal cell adhesion molecule (B-CAM), a cell surface antigen of epithelial cancer, has been cloned and shown to be also a new IgSF member with the V-V-C2-C2-C2 arrangement of immunoglobulin domains.6 cDNA sequence comparison provided the first indication of a relationship between B-CAM and Lu and indicated that the predicted amino acid sequence of B-CAM differed from that of the 85 kD Lu gp only by the lack of the last 40 amino acids of the cytoplasmic tail. 5 However, available nucleotide sequence on the 3' untranslated region of the two cDNAs exhibited no homology. CAM DNA probe. Sequence comparison between cDNA and genomic PCR fragments indicated that the Lu and B-CAM transcripts previously isolated are generated through the alternative use of internal splice donor and acceptor sites within an exon located at the 3' end of the LU gene. These spliceoforms corresponded t o 2.5 kb and 4.0 kb mRNA species detectable by Northern blot in all tissues and cell lines in which the L U gene is expressed; their primary structures are consistent with the presence of both the Lu and B-CAM antigens on two glycoprotein isoforms. However, the 4.0 kb transcript was very poorly expressed as compared to the 2.5 kb species except in the colon carcinoma HT29 cell line, suggesting a differential regulation of the Lu/B-CAM messenger RNA in some tumor tissues. 0 1996 by The American Society of Hematology.
The B-CAM antigen was first identified by monoclonal antibodies (MoAbs) raised against human tumor cells and was shown to be overexpressed in ovarian carcinomas in vivo and upregulated following malignant transformation in some cell type^."^ In addition, B-CAM was expressed in a variety of normal human tissues and cells but not on hematopoietic cells.''
The role of Lu and B-CAM antigens is yet to be clarified, but their structural homology with the MUC18 human cell surface antigen of invasive melanoma "," and the SC1 chicken neural adhesion molecule,'' two other IgSF members with the V-V-C2-C2-C2 domain structures known as cellular adhesion molecules, suggested that they may share similar functions. In this context, it has already been observed that substrate-adherent growth of some cell types might be correlated with B-CAM expre~sion.'.'~ In this report, we show that the previously isolated Lu and B-CAM cDNA clone^^,^ represent alternatively spliced transcripts of a unique gene on chromosome 19q13.2-13.3. The structure and tissue distribution of these mRNA spliceoforms are consistent with the immunocharacterization of two Lu and B-CAM active glycoproteins in various cells. Appligene (Strasbourg, France). T4 DNA ligase and polynucleotide kinase were from Biolabs (Northbrook, IL) and radiolabeled nucleotides from Amersham (Bucks, UK). Thermus aquaticus polymerase (Taq Polymerase) was purchased from Life Technologies (Gaitherburg, CA). The random priming labelling kit came from Boehringer (Mannheim, Germany). T7 cycling sequencing kit was from Pharmacia (Uppsala, Sweden). DNA probes. Lu andor B-CAM cDNA probes were made by polymerase chain reaction (PCR) amplification using primers designed from available sequence informations'.' (see Fig l) . The PCRl probe was amplified between primers LBI and LB32 (see Table 1 for oligonucleotide sequences) and corresponded to the common sequence of Lu and B-CAM cDNAs between nt 1 4 to nt + 1,761 (+ 1 taken as the first residue of the initiator AUG). PCR2
was amplified between primers L36 and L37 and corresponded to nt 1,891 to nt 1,982 of the Lu specific 3' noncoding sequence. PCR3 was amplified between primers B1 and B3 and corresponded to nt 1,769 to 1,912 of the B-CAM specific 3' untranslated region. The 1,039 bp PCR4 probe was made by genomic PCR arnplification between primers LB44 and L2 (see Fig 3 and Table l) , and was used as specific B-CAM probe (nt + 1,744 to 2,782 of the B-CAM transcript). The amplified cDNAs were electroeluted from agarose gels and labeled by the random priming method (specific activity, 5 X 10' to lo9 c p d p g ) to be used as probes.
Southern analysis. Human genomic DNA extracted from peripheral leukocytes was digested with restriction enzymes (10 UIpg DNA), resolved by electrophoresis in 0.8% (wt/vol) agarose gels and transferred as described by Southern to a nylon membrane GT (Bio-Rad, Hercules, CA). Hybridization with cDNA probes (2 X IO6 cpdmL) was performed for 16 hours at 65°C according to the manufacturer's recommendations, and final washings were done at 65°C in 40 mmoUL Na-phosphate, 0.1% (wt/vol) sodium dodecyl sulfate (SDS) for 20 minutes.
PCR ampl$cation of RNA and genomic sequences. Genomic DNA was used as a template for PCR amplification using primer LB44 as a 5' primer and L2 or B2 as 3' primers ( Table 1 and Fig  3) . Five micrograms of total cellular RNA from human kidney and human fetal brain (Clontech, Palo Alto, CA) were used for cDNA preparations with a kit from Pharmacia. About 500 ng of the first strand cDNA was used as a template for PCR amplification with Table 1 for annealing temperatures) and extension at 72°C for 1.5 minutes.
DNA sequencing. cDNA and genomic inserts were subcloned into the pUC18 vector and sequenced on both strands by chain termination method with a Pharmacia T7 sequencing kit, using universal primers or specific oligonucleotides as internal primers.
Northern blot analysis. Northern blots were prepared as described with 15 ,ug of total RNAs from different human cell lines or 2 pg of poly(A+) RNAs from normal tissues. Multitissue northern (MTN) blots were purchased from Clontech. Hybridization with the PCRl, PCR2, and PCR4 probes were performed at 65°C in 7% (wt/vol) SDS, 300 mmol/L Na-phosphate. Stringent washes were performed at 65°C in 40 mmol/L Na-phosphate, 0.1% (wt/vol) SDS for 20 minutes.
In situ chromosome hybridization. The PCRl probe was used for chromosome hybridization on metaphasic cells obtained from phytohemagglutinin-stimulated peripheral blood lymphocytes for 72 hours. The conditions for probe labeling, hybridization, washings, and for visualization of hybridization on chromosomes were as described." 
RESULTS

Comparison of the
PCR2
tween nucleotides -6 to +1,764 raised the question as to as PCR1, but it detected only the 10 kb fragment in the whether these two cDNA species derived from the same gene BamHI digest (Fig 2B) . Interestingly, the B-CAM PCR3 or from two highly related genes. To resolve this problem, 3 probe exhibited the same hybridization pattern to that of the primer sets were designed (see Materials and Methods and PCR2 probe (Fig 2C) . Fig l) , to construct DNA probes specific of the 3' end of These results, particularly the finding that the B-CAM Lu and B-CAM cDNAs (PCW and PCR3, respectively) and PCR3 probe revealed the Lua/Lub associated HindIII RFLP, for nucleotide sequence encoding the common extracellular and intramenbraneous domains of Lu and B-CAM gps (PCRI).
In situ chromosome hybridization of the LdB-CAM cDNA probe. When the LulB-CAM PCRl probe was used for in situ hybridization to human metaphasic chromosomes, a unique signal was detected on chromosome 19. In the 100 metaphases examined, 29.8% of the silver grains associated to chromosome 19 and 79.8% of them mapped to the 19q13.2-q13.3 region (not shown). strongly suggested that the Lu and B-CAM cDNAs derived from a unique LU gene by a mechanism, which will be further explored below.
PCR amplification of Lu and /or B-CAM cDNAs and genomic DNA sequences. cDNA sequence comparison indicated that the first nucleotides of B-CAM which differ from the Lu sequence correspond to those of a consensus splice donor site (ETGAG, nt 1,765 to 1,769, see Fig 3) . This observation suggested that the downstream sequence of the B-CAM mRNA was transcribed from a region of the LU Southern blot analysis of the human Lutheran and B-CAM gene which was skipped from the Lu mRNA by splicing loci. As a first approach to investigate the relationship beat an internal splice donor site. Alternative splicing of the tween the gene(s) encoding the Lu and B-CAM gps, Southsequence, downstream of the junction between Lu and Bern blot analysis of genomic DNA from unrelated donors serologically typed as Lu(a+b-) (n = 2), Lu(a-b+) (n = 4), and Lu(a+b+) (n = 7) was performed with the PCRl probe common to the Lu and B-CAM cDNAs, the PCR2 probe specific of the Lu sequence and the PCR3 probe specific of the B-CAM sequence (see above). On BamHI digests, the Lu/B-CAM PCRl probe detected three fragments (18 kb, 10 kb, and 0.5 kb), regardless of the Lua/Lub status of the samples (Fig 2A) . In contrast, PCRl revealed on HindIII digests a restriction fragment length polymorphism (RFLP) associated with the expression of the Lu" and Lub antigens, because either a 22 kb or a 20 kb HindIII fragment was detected in the homozygous Lu(a+b-) or Lu(a-b+) samples, respectively. Both fragments were present in the heterozygous Lu(a+b+) samples. However, this RFLP most likely did not identify the site of the Lua/Lub antigenic polymorphism but rather represented a linked DNA polymorphism in a non coding region of the LU gene, since the coding sequence of the published Lub cDNA5 did not contain any HindIII recognition site and the HindIII genomic fragment carrying the Lu" allele was shown here to be longer than that carrying the Lub allele.
The Lu PCR2 probe revealed the same HindIII patterns CAM cDNAs, was assessed by comparing the PCR products obtained when cDNA (kidney or fetal brain) or genomic DNA were used as templates for amplification between primers surrounding the Lu/B-CAM divergence site (nt 1,765). The same 70 bp PCR product was amplified from cDNA or genomic DNA with the B-CAM specific primer set LB44-B2;whereas the Lu specific primer set LB44-L2 amplified fragments of 61 bp and 1,039 bp from cDNA and genomic DNA templates, respectively (not shown). These results indicate that within the LU gene region under study, the Lu but not the B-CAM coding region was disrupted by a DNA sequence of 978 bp (Fig 3) . Sequence analysis revealed a complete homology between the 5' half of this 978 bp genomic fragment (Fig 4) and the partial 3' untranslated region of the B-CAM cDNA previously published (nt 1,765 to nt 2,390). Southern andor sequencing analysis of the 765 bp and 556 bp PCR products, obtained after amplification of cDNA templates between primer sets B4-L37 and B9-L45 (see Fig 3) , indicated that the uncharacterized 3' end of the B-CAM cDNA correspond to the 3' half of the 978 bp sequence followed by the sequence of the published Lu cDNA from nt 1,764 to the poly(A) addition ~i t e .~.~ In the course of this study, we also characterized an intron of 92
For personal use only. on September 24, 2017. by guest www.bloodjournal.org bp which disrupted the LU coding sequence just before the last codon, ie, at a position corresponding to the 3' noncoding region of B-CAM (Figs 3 and 4) . The genomic and cDNA sequence analysis reported here demonstrated that the Lu and B-CAM cDNAs (from nt -6 to the poly(A) addition site) represent RNA spliceofoms of
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" " " " " " " " " _ " _" " " " " " " " " " " " " " " " " " "_"" " " " _ " _ " " " Northern Mot. Whereas the Lu and B-CAM cDNAs were previously shown to recognize a singlesize mRNA species of 2.5 kb5 or 3.0 kb' in several normal human tissues (heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas), we detected two signals at 2.5 kb and 4.0 kb with the Lu/B-CAM PCRl probe in the same tissues and others of adult and fetal origin, as well as in the cell lines HeLa and HT29 (Fig SA) . Among hematopoietic tissues and cells. the two transcripts were found in human bone marrow and erythroid spleen but neither in leukocytes nor in HEL and K562 erythroleukemic cell lines. The size difference between the two mRNA species was consistent with the size of the alternatively spliced Lu/B-CAM sequence described above. Furthermore, the PCR4 probe corresponding to the 978 bp DNA region spliced from the Lu mRNA revealed only the 4.0 k.b transcript in all tissues where the LU gene was expressed (Pig SB). These results, together with the sequence analysis previously reported, showed that the 2.5 kb and 4.0 kb mRNA species correspond to the previously published Lu and B-CAM cDNAs,'.' respectively. However, it is noteworthy that the level of the 4.0 kb transcripts was very low as compared to that of the 2.5 kb species in all tissues and cell lines, except in the colon carcinoma HT29 cell line (Fig S ) . DISCUSSION We have shown that the Lu and B-CAM cDNA clones encoding the erythrocyte 85 kD Lu blood group active glycoprotein' and the B-CAM epithelial cancer antigen.' respectively, represent alternatively spliced transcripts of a single LU gene. This conclusion is supported by the following results: ( 1 ) sequence homology between Lu and B-CAM cDNAs and chromosomal localization of the Lu ( 5 and present results) and B-CAM' probes to chromosome 19q13.2-13.3: (2) PCR probes designed from the 3' untranslated sequences specific to each cDNA clones detected the same single copy gene and revealed the same Hind11 RFLP associated with the Lu"/Luh blood group polymorphism: (3) amplification and sequence analysis of the 3' end of the LU gene, and of the uncharacterized 3' end of the B-CAM cDNA, indicated that the only difference between the Lu and B-CAM cDNAs was the presence in the latter of an additional 978 bp sequence flanked by consensus splice donor and acceptor motifs. Alternative use of these internal splice sites was deduced from the characterization with relevant probes of the 2.5 kb and 4.0 kb Lu/B-CAM mRNA species on Northern blots.
In previous immunochemical studies, a rabbit antiserum raised against the cytoplasmic and/or transmembrane domains of erythrocyte Lu gp was shown to precipitate the Lu gps of apparent molecular weight 85 but not 78 kD from unsealed membranes, suggesting that these two components may represent protein isoforms. although the 78 kD gp may simply be a proteolytic fragment of the 85 kD gp.' Our results suggest that the alternative splicing event previously described ( leading to the synthesis of Lu and B-CAM gps cloned from placenta tissue and colon carcinoma HT29 cells, respectively) could account for the presence of 85 and 78 kD Lu active components in erythrocyte membranes. This hypothesis is susbtantiated by Northern blot analysis showing the presence of the 2.5 and 4.0 kb Lu/B-CAM transcripts isoforms in bone marrow and erythroblast RNA preparations. The difference of 7 kD between the two Lu gp species might be accounted for by the extra 40 amino acids (calcu- Other independent immunocytochemical studies performed with anti-Lu5 or anti-B-CAM6 MoAbs strongly suggest that the tissue distributions of the Lu and B-CAM antigens are similar. However, further investigations will be necessary to determine whether, in nonerythroid cells and tissues, which, like HT29 express both B-CAM9 and Lub (our unpublished data) antigens, the Lu and B-CAM epitopes are carried by the same molecules or by different glycosylation isoforms.
Northern blot analysis performed in the course of this study confirmed that the LU gene was widely expressed in normal tissues and upregulated in fetal versus adult stages (at least in lung, liver, and kidney) and suggests that the long tail L O -C A M gp (encoded by the 2.5 kb transcript) was predominantly expressed as compared to the short tail isoform (encoded by the 4.0 kb transcript), except in the colon carcinoma cell line HT29. The Lu/B-CAM gp carrying a long cytoplasmic tail contained a consensus binding site for SH3 motif^,^ which was absent from the short cytoplasmic tail isoform. Because molecules carrying SH3 elements are involved in intracellular signaling pathways," it can be speculated that alternative splicing of the cytoplasmic domain may affect the potential function of the LU encoded proteins. Similarly, it has been proposed that alternative splicing of the cytoplasmic tail of CD44 glycoproteins, which exhibited potential sites for protein kinases A and C, might be related to the potential role of the CD44 variants in T-cell activation by modulating intracellular signaling."
Further investigations should determine whether differential regulation of the alternative splicing of the Lu/B-CAM messenger leading to overexpression of the short tail isoform, might be associated with malignant transformation and to the nonpolarized expression of B-CAM observed in epithelial ovary cance~s.~
